Search

everythinglearnresearchcommunity

for

Search:↓

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Testosterone may influence COVID-19 severity and outcomes.

Some drugs may help treat both COVID-19 and radiation injury.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

The Polish Medical Association in Chicago effectively supported the Polish community during COVID-19.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Antiandrogens don't help with COVID-19 and aren't recommended.

Gender and social factors, not just biology, affect COVID-19 death rates.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

The pandemic worsened physical and mental challenges for women with PCOS.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Effective pre- and post-operative care is crucial for better outcomes in sleeve gastrectomy patients.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

COVID-19 can cause temporary hair loss.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

COVID-19 may cause hair loss by affecting hair follicles.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.